GSC
GOSS icon

Ground Swell Capital’s Gossamer Bio GOSS Stock Holding History

Ground Swell Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65K Sell
10,000
-5,356
-35% -$1.5K ﹤0.01% 143
2026
Q1 		$5.04K Buy
+15,356
New +$24.1K 0.01% 113
2023
Q2 		– Sell
-13,437
Closed -$16.9K – 73
2023
Q1 		$16.9K Buy
+13,437
New +$25.7K 0.03% 44

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Ground Swell Capital's GOSS Position: Q2 2026 in Review

Ground Swell Capital reduced its Gossamer Bio (GOSS) stake by 35% in Q2 2026, selling an estimated $1.5K and leaving 10,000 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #143.

Ground Swell Capital first reported a position in GOSS in Q1 2023 and has held it in 3 quarters since. The position peaked at $16.9K in Q1 2023. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Ground Swell Capital held 10,000 shares of Gossamer Bio worth $1.65K as of Q2 2026.
  • Ground Swell Capital sold 5,356 Gossamer Bio shares in Q2 2026, an estimated $1.5K.
  • Gossamer Bio made up ﹤0.01% of Ground Swell Capital's portfolio in Q2 2026, its #143 holding.
  • Ground Swell Capital first reported a position in Gossamer Bio in Q1 2023 and has held it in 3 quarters since.
  • Ground Swell Capital's Gossamer Bio position peaked at $16.9K in Q1 2023.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Ground Swell Capital's 13F filing for Q2 2026, filed 5 Aug 2026.